
Longevitytech.fund
Description
Longevitytech.fund is a specialized venture capital firm based in Boca Raton, United States, dedicated to investing globally in pre-seed and seed-stage startups developing technologies aimed at extending healthy human lifespans. The fund's investment thesis centers on supporting innovative companies at the intersection of biotechnology, healthcare, and deep tech, with a strong emphasis on scientific rigor and groundbreaking research. They adopt a hands-on approach, actively collaborating with their portfolio companies to foster growth and navigate the complex landscape of longevity science.
The firm is known for its focused strategy within the burgeoning longevity sector, identifying early-stage ventures with high potential for disruptive impact. Longevitytech.fund typically deploys initial checks ranging from $100,000 to $500,000, providing crucial early capital to help founders validate their concepts and achieve key milestones. Their commitment extends beyond mere capital, offering strategic guidance and leveraging their network to support the development of groundbreaking solutions.
With a portfolio that includes over 25 investments, Longevitytech.fund has established itself as an active and prominent player in the longevity investment space. Their global reach allows them to identify promising opportunities worldwide, contributing to the advancement of technologies that could significantly improve human health and extend vitality. The fund's strategic location in Florida also places it within a growing hub for biotech and health innovation.
Investor Profile
Longevitytech.fund has backed more than 45 startups, with 1 new investments in the last 12 months alone. The firm has led 13 rounds, about 29% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Convertible Note, Pre Seed rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, The Netherlands.
- Strong thematic focus on Biotechnology, Health Care, Life Science.
- Led 1 rounds in the past year.
- Typical check size: $100K – $500K.
Stage Focus
- Seed (44%)
- Convertible Note (27%)
- Pre Seed (20%)
- Series Unknown (4%)
- Equity Crowdfunding (2%)
- Series A (2%)
Country Focus
- United States (69%)
- United Kingdom (18%)
- The Netherlands (4%)
- Germany (2%)
- Greece (2%)
- Israel (2%)
- Finland (2%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Health Diagnostics
- Pharmaceutical
- Biopharma
- Therapeutics
- Medical Device
- Artificial Intelligence (Ai)
- Medical
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.